[["ABIM Laboratory Test Reference","Ranges  \u0336 January 2025"],["Laboratory Tests","Reference Ranges"],["1,25-Dihydroxyvitamin D","See Vitamin D metabolites"],["(1,25-dihydroxycholecalciferol), serum",""],["1,5-Anhydroglucitol, serum or plasma","Female: 6.8\u201329.3 \u03BCg/mL; male: 10.7\u201332 \u03BCg/mL"],["17-Hydroxycorticosteroids (Porter-Silber), urine","Female: 2\u20138 mg/24 hr; male: 3\u201310 mg/24 hr"],["17-Hydroxyprogesterone, serum",""],["Female, follicular","\u02C280 ng/dL"],["Female, luteal","\u02C2285 ng/dL"],["Female, postmenopausal","\u02C251 ng/dL"],["Male (adult)","\u02C2220 ng/dL"],["25-Hydroxyvitamin D","See Vitamin D metabolites"],["(25-hydroxycholecalciferol), serum",""],["5-Hydroxyindoleacetic acid, urine","2\u20139 mg/24 hr"],["5\u0027-Nucleotidase, serum","0.3\u20132.6 (Bodansky) units/dL (0\u201315 U/L)"],["6-Thioguanine, whole blood","230\u2013400 pmol/8x10 8 RBCs"],["LBDBANO","0\u2013110/\u03BCL"],["LBDEONO","0\u2013330/\u03BCL"],["LBDLYMNO","1200\u20134950/\u03BCL"],["LBDMONO","0\u2013660/\u03BCL"],["LBDNENO","2000\u20138250/\u03BCL"],["Acid phosphatase, serum",""],["Total","0.5\u20132.0 (Bodansky) units/mL"],["Prostatic fraction","0.1\u20130.4 unit/mL"],["ACTH, plasma","10\u201360 pg/mL"],["Activated partial thromboplastin time","25\u201335 seconds"],["ADAMTS13 activity","\u003E60%"],["Adrenocorticotropic hormone (ACTH), plasma","10\u201360 pg/mL"],["LBXSAL","3.5\u20135.5 g/dL"],["Albumin, urine","\u02C225 mg/24 hr"],["Albumin-to-creatinine ratio, urine","\u02C230 mg/g"],["Aldolase, serum","0.8\u20133.0 IU/mL"],["Aldosterone, plasma",""],["Supine or seated","\u226410 ng/dL"],["Standing","\u02C221 ng/dL"],["Low-sodium diet (supine)","\u226430 ng/dL"],["Aldosterone, urine","5\u201319 \u03BCg/24 hr"],["LBXSAPSI","30\u2013120 U/L"],["Alpha 1 -antitrypsin (AAT), serum","150\u2013350 mg/dL"],["Alpha 2 -antiplasmin activity, plasma","75%\u2013115%"],["Alpha-amino nitrogen, urine","100\u2013290 mg/24 hr"],["Alpha-fetoprotein, serum","\u02C210 ng/mL"],["Amino acids, urine","200\u2013400 mg/24 hr"],["LBXSATSI","10\u201340 U/L"],["LBXSASSI","10\u201340 U/L"],["Ammonia, plasma","40\u201370 \u03BCg/dL"],["Amylase, serum","25\u2013125 U/L (80\u2013180 [Somogyi] units/dL)"],["Amylase, urine","1\u201317 U/hr"],["Androstenedione, serum","Female: 30\u2013200 ng/dL; male: 40\u2013150 ng/dL"],["Angiotensin-converting enzyme, serum","8\u201353 U/L"],["Anion gap, serum","7\u201313 mEq/L"],["Antibodies to double-stranded DNA","0\u20137 IU/mL"],["Anticardiolipin antibodies",""],["IgG","\u02C220 GPL"],["IgM","\u02C220 MPL"],["Anti-cyclic citrullinated peptide antibodies","\u02C220 units"],["Antideoxyribonuclease B","\u02C2280 units"],["Anti-F-actin antibodies, serum","\u22641:80"],["Antihistone antibodies","\u02C21:16"],["Anti-liver-kidney microsomal antibodies (anti-LKM)","\u02C21:20"],["Antimitochondrial antibodies","\u22641:5"],["Anti\u2013myelin associated glycoprotein antibody","\u02C21:1600"],["Antimyeloperoxidase antibodies","\u02C21.0 U"],["Antinuclear antibodies","\u22641:40"],["Anti-phospholipase A2 receptor (PLA2R) antibodies,","Negative: \u003C14 RU/mL"],["serum","Borderline: 14 \u2013 \u003C20 RU/mL"],["[ELISA]","Positive: \u226520 RU/mL"],["Anti-RNP antibodies","\u003C20 CU"],["[by chemiluminescence method]",""],["Anti-RNP antibodies","\u003C1.0 AI"],["[by multiplex flow immunoassay]",""],["Anti-Scl-70 antibodies (topoisomerase 1 antibodies), IgG,","Negative: \u003C1.0 U"],["serum","[Positive: \u22651.0 U]"],["Anti\u2013smooth muscle antibodies","\u22641:80"],["Anti-SSA/Ro \u0026 anti-SSB antibodies","\u003C20 CU"],["[by chemiluminescence method]",""],["Anti-SSA/Ro \u0026 anti-SSB antibodies","\u003C1.0 AI"],["[by multiplex flow immunoassay]",""],["Antistreptolysin O titer","\u02C2200 Todd units"],["Antithrombin activity","80%\u2013120%"],["Antithyroglobulin antibodies","\u02C220 U/mL"],["Antithyroid peroxidase antibodies","\u02C22.0 U/mL"],["Anti-tissue transglutaminase antibodies","See Tissue transglutaminase antibody"],["Apolipoprotein A-1, serum","Female: \u2265140 mg/dL"],["","Male: \u2265120 mg/dL"],["Apolipoprotein B, serum","Desirable: \u02C290 mg/dL"],["","Borderline high: 90\u2013119 mg/dL"],["","High: 120\u2013139 mg/dL"],["","Very High: \u2265140 mg/dL"],["Arterial blood gas studies (patient",""],["breathing room air):",""],["pH","7.38\u20137.44"],["PaCO 2","3842 mm Hg"],["PaO 2","75\u2013100 mm Hg"],["Bicarbonate","23\u201326 mEq/L"],["Oxygen saturation","\u226595%"],["Methemoglobin","0.5%\u20133.0%"],["Ascorbic acid (vitamin C), blood","0.4\u20131.5 mg/dL"],["Ascorbic acid, leukocyte","16.5 \u00B1 5.1 mg/dL of leukocytes"],["","2"],["(1,3)-Beta-D-glucan, serum","\u02C260 pg/mL"],["Beta-human chorionic gonadotropin (beta-hCG), serum","Female, premenopausal nonpregnant: \u02C21.0 U/L;"],["","female, postmenopausal: \u02C27.0 U/L; male: \u02C21.4 U/L"],["Beta-human chorionic gonadotropin (beta-hCG), urine","\u02C22 mIU/24 hr"],["Beta 2 -glycoprotein I antibodies:",""],["IgG","\u02C221 SGU"],["IgM","\u02C221 SMU"],["Beta-hydroxybutyrate, serum","\u02C20.4 mmol/L"],["Beta 2 -microglobulin, serum","0.54\u20132.75 mg/L"],["LBXSC3SI","23\u201328 mEq/L"],["LBXSTB",""],["Total","0.3\u20131.0 mg/dL"],["Direct","0.1\u20130.3 mg/dL"],["Indirect","0.2\u20130.7 mg/dL"],["Bleeding time (template)","\u02C28 minutes"],["LBXSBU","8\u201320 mg/dL"],["Bone-specific alkaline phosphatase, serum","Female, premenopausal: 4.5\u201316.9 \u00B5g/L"],["","Female, postmenopausal: 7.0\u201322.4 \u00B5g/L"],["","Male, 25 years of age or older: 6.5\u201320.1 \u00B5g/L"],["B-type natriuretic peptide, plasma","\u02C2100 pg/mL"],["C peptide, serum","0.8\u20133.1 ng/mL"],["Calcitonin, serum","Female: \u22645 pg/mL; male: \u226410 pg/mL"],["Calcium, ionized, serum","1.12\u20131.23 mmol/L"],["LBXSCA","8.6\u201310.2 mg/dL"],["Calcium, urine","Female: \u02C2250 mg/24 hr; male: \u02C2300 mg/24 hr"],["Carbohydrate antigens, serum",""],["CA 19-9","0\u201337 U/mL"],["CA 27-29","\u02C238.0 U/mL"],["CA 125","\u02C235 U/mL"],["Carbon dioxide, serum","23\u201330 mEq/L"],["Carboxyhemoglobin, blood","\u02C25%"],["Carcinoembryonic antigen, plasma","\u02C22.5 ng/mL"],["Carotene, serum","75\u2013300 \u03BCg/dL"],["Catecholamines, plasma",""],["Dopamine","\u02C230 pg/mL"],["Epinephrine",""],["Supine","\u02C250 pg/mL"],["Standing","\u02C295 pg/mL"],["Norepinephrine",""],["Supine","112\u2013658 pg/mL"],["Standing","217\u20131109 pg/mL"],["Catecholamines, urine",""],["Dopamine","65\u2013400 \u03BCg/24 hr"],["Epinephrine","2\u201324 \u03BCg/24 hr"],["Norepinephrine","15\u2013100 \u03BCg/24 hr"],["Total","26\u2013121 \u03BCg/24 hr"],["CD4 T-lymphocyte count","530\u20131570/\u03BCL"],["Cell count, CSF:",""],["Leukocytes (WBCs)","0\u20135 cells/\u03BCL"],["Erythrocytes (RBCs)","0/\u00B5L"],["Ceruloplasmin, serum (plasma)","25\u201343 mg/dL 3"],["Chloride, CSF","120\u2013130 mEq/L"],["LBXSCLSI","98\u2013106 mEq/L"],["Chloride, urine",""],["Random (\u0022spot\u0022)","mEq/L; varies"],["24-hour measurement","mEq/24 hr; varies with intake"],["LBXSCH",""],["Total",""],["Desirable","\u02C2200 mg/dL"],["Borderline-high","200\u2013239 mg/dL"],["High","\u003E239 mg/dL"],["High-density lipoprotein",""],["Low","Female: \u02C250 mg/dL; male: \u02C240 mg/dL"],["Low-density lipoprotein",""],["Optimal","\u02C2100 mg/dL"],["Near-optimal","100\u2013129 mg/dL"],["Borderline-high","130\u2013159 mg/dL"],["High","160\u2013189 mg/dL"],["Very high","\u003E189 mg/dL"],["Cholinesterase, serum (pseudocholinesterase)","\u22650.5 pH unit/hr"],["Packed cells","\u22650.7 pH unit/hr"],["Chorionic gonadotropin, beta-human","See Beta-human chorionic gonadotropin (beta-hCG),"],["(beta-hCG), serum","serum"],["Chorionic gonadotropin, beta-human","See Beta-human chorionic gonadotropin (beta-hCG),"],["(beta-hCG), urine","urine"],["Chromogranin A, serum","\u02C293 ng/mL"],["Citrate, urine","250\u20131000 mg/24 hr"],["Coagulation factors, plasma",""],["Factor I (fibrinogen)","200\u2013400 mg/dL"],["Factor II (prothrombin)","60%\u2013130%"],["Factor V (accelerator globulin)","60%\u2013130%"],["Factor VII (proconvertin)","60%\u2013130%"],["Factor VIII (antihemophilic globulin)","50%\u2013150%"],["Factor IX (plasma thromboplastin component)","60%\u2013130%"],["Factor X (Stuart factor)","60%\u2013130%"],["Factor XI (plasma thromboplastin antecedent)","60%\u2013130%"],["Factor XII (Hageman factor)","60%\u2013130%"],["Factor XIII","57%\u2013192%"],["Cold agglutinin titer","\u003E1:64 positive"],["Complement components, serum",""],["C3","100\u2013233 mg/dL"],["C4","14\u201348 mg/dL"],["CH50","110\u2013190 units/mL"],["Copper, serum","100\u2013200 \u03BCg/dL"],["Copper, urine","0\u2013100 \u03BCg/24 hr"],["Coproporphyrin, urine","50\u2013250 \u03BCg/24 hr"],["Cortisol, free, urine","4\u201350 \u03BCg/24 hr"],["Cortisol, plasma",""],["8 AM","5\u201325 \u03BCg/dL"],["4 PM","\u02C210 \u03BCg/dL"],["1 hour after cosyntropin","\u226518 \u03BCg/dL"],["Overnight suppression test (1-mg)","\u02C21.8 \u03BCg/dL"],["Overnight suppression test (8-mg)","\u003E50% reduction in cortisol"],["Cortisol, saliva, 11 PM \u2013 midnight","\u02C20.09 \u00B5g/dL 4"],["C-reactive protein, serum","\u22640.8 mg/dL"],["C-reactive protein (high sensitivity), serum","Low cardiovascular risk: \u02C21.0 mg/L;"],["","Average cardiovascular risk: 1.0\u20133.0 mg/L;"],["","High cardiovascular risk: \u003E3.0 mg/L"],["Creatine kinase, serum",""],["Total","Female: 30\u2013135 U/L; male: 55\u2013170 U/L"],["MB isoenzymes","\u02C25% of total"],["Creatine, urine","Female: 0\u2013100 mg/24 hr; male: 0\u201340 mg/24 hr"],["Creatinine clearance, urine","90\u2013140 mL/min/1.73 m 2"],["LBXSCR","Female: 0.50\u20131.10 mg/dL; male: 0.70\u20131.30 mg/dL"],["Creatinine, urine",""],["Random (\u0022spot\u0022)","mg/dL; varies"],["24-hour measurement","15\u201325 mg/kg body weight/24 hr"],["D-dimer, plasma","\u02C20.5 \u03BCg/mL"],["Dehydroepiandrosterone sulfate (DHEA-S), serum","Female: 44\u2013332 \u03BCg/dL; male: 89\u2013457 \u03BCg/dL"],["Delta-aminolevulinic acid, serum","\u02C220 \u03BCg/dL"],["Dihydrotestosterone, serum","Adult male: 25\u201380 ng/dL"],["Dopamine, plasma","\u02C230 pg/mL"],["Dopamine, urine","65\u2013400 \u03BCg/24 hr"],["D-Xylose absorption",""],["(after ingestion of 25 g of D-xylose)",""],["Serum","25\u201340 mg/dL"],["Urinary excretion","4.5\u20137.5 g during a 5-hr period"],["Electrolytes, serum",""],["Sodium","136\u2013145 mEq/L"],["Potassium","3.5\u20135.0 mEq/L"],["Chloride","98\u2013106 mEq/L"],["Bicarbonate","23\u201328 mEq/L"],["Epinephrine, plasma",""],["Supine","\u02C2110 pg/mL"],["Standing","\u02C2140 pg/mL"],["Epinephrine, urine","\u02C220 \u03BCg/24 hr"],["LBXRBCSI","4.2\u20135.9 million/\u03BCL"],["Erythrocyte sedimentation rate (Westergren)","Female: 0\u201320 mm/hr; male: 0\u201315 mm/hr"],["Erythrocyte survival rate ( 51 Cr)","T\u00BD = 28 days"],["Erythropoietin, serum","4\u201326 mU/mL"],["Estradiol, serum",""],["Female, follicular","10\u2013180 pg/mL"],["Mid-cycle peak","100\u2013300 pg/mL"],["Luteal","40\u2013200 pg/mL"],["Postmenopausal","\u02C210 pg/mL"],["Male","20\u201350 pg/mL"],["Estriol, urine","\u003E12 mg/24 hr"],["Estrogen receptor protein","Negative: \u02C210 fmol/mg protein"],["Estrone, serum","10\u201360 pg/mL"],["Ethanol, blood","\u02C20.005% (\u02C25 mg/dL)"],["Coma level","\u003E0.5% (\u003E500 mg/dL)"],["Intoxication","\u22650.08%\u20130.1% (\u226580\u2013100 mg/dL)"],["Euglobulin clot lysis time","2\u20134 hours at 37.0 C"],["Factor XIII, B subunit, plasma","60\u2013130 U/dL"],["","5"],["Fecal fat","\u02C27 g/24 hr"],["Fecal pH","7.0\u20137.5"],["Fecal weight","\u02C2250 g/24 hr"],["Ferritin, serum","Female: 24\u2013307 ng/mL; male: 24\u2013336 ng/mL"],["Fibrin(ogen) degradation products","\u02C210 \u03BCg/mL"],["Fibrinogen, plasma","200\u2013400 mg/dL"],["Fibroblast growth factor-23, serum","30\u201380 RU/mL"],["Folate, red cell","150\u2013450 ng/mL of packed cells"],["Folate, serum","1.8\u20139.0 ng/mL"],["Follicle-stimulating hormone, serum",""],["Female, follicular/luteal","2\u20139 mIU/mL (2\u20139 U/L)"],["Female, mid-cycle peak","4\u201322 mIU/mL (4\u201322 U/L)"],["Female, postmenopausal","\u003E30 mIU/mL (\u003E30 U/L)"],["Male (adult)","1\u20137 mIU/mL (1\u20137 U/L)"],["Children, Tanner stages 1, 2","0.5\u20138.0 mIU/mL (0.5\u20138.0 U/L)"],["Children, Tanner stages 3, 4, 5","1\u201312 mIU/mL (1\u201312 U/L)"],["Free kappa light chain, serum","3.3\u201319.4 mg/L"],["Free kappa-to-free lambda light chain ratio, serum","0.26\u20131.65"],["Free lambda light chain, serum","5.7\u201326.3 mg/L"],["Gamma globulin, CSF","6.1\u20138.3 mg/dL"],["LBXSGTSI",""],["(gamma-glutamyl transpeptidase), serum","Female: 8\u201340 U/L; male: 9\u201350 U/L"],["Gastrin, serum","\u02C2100 pg/mL"],["Glucose, CSF","50\u201375 mg/dL"],["LBXSGL","70\u201399 mg/dL"],["Glucose-6-phosphate dehydrogenase, blood","5\u201315 units/g of hemoglobin"],["Glycoprotein \u03B1-subunit, serum","\u02C21 ng/mL"],["Growth hormone, serum",""],["At rest","\u02C25 ng/mL"],["Response to provocative stimuli","\u003E7 ng/mL"],["Haptoglobin, serum","83\u2013267 mg/dL"],["LBXHCT","Female: 37%\u201347%; male: 42%\u201350%"],["Hemoglobin A 1C","4.0%\u20135.6%"],["LBXHGB","Female: 12\u201316 g/dL; male: 14\u201318 g/dL"],["Hemoglobin fractionation",""],["Hb A","96%\u201398%"],["Hb A 2","1.5%\u20133.5%"],["Hb F","\u02C21%"],["Hemoglobin, plasma","\u02C25.0 mg/dL"],["Heparin\u2013anti-factor Xa assay, plasma","0.3\u20130.7 IU/mL [therapeutic range for standard"],["","(unfractionated) heparin therapy]"],["Heparin\u2013platelet factor 4 antibody, serum","Positive: \u003E0.4 optical density unit"],["Hepatic copper","25\u201340 \u03BCg/g dry weight"],["Hepatic iron index","\u02C21.0"],["Histamine excretion, urine","20\u201350 \u03BCg/24 hr"],["Homocysteine, plasma","5\u201315 \u03BCmol/L"],["\u03B2-Human chorionic gonadotropin (\u03B2-hCG), serum","Female, premenopausal nonpregnant: \u02C21.0 U/L; female,"],["","postmenopausal: \u02C27.0 U/L; male: \u02C21.4 U/L"],["\u03B2-Human chorionic gonadotropin (\u03B2-hCG), urine","\u02C22 mIU/24 hr"],["Hydroxyproline, urine","10\u201330 mg/sq meter of body surface/24 hr"],["","6"],["Immature platelet fraction","1%\u20135% of platelet count"],["Immune complexes, serum","0\u201350 \u03BCg/dL"],["Immunoglobulins, serum",""],["IgA","90\u2013325 mg/dL"],["IgE","\u02C2380 IU/mL"],["IgG","800\u20131500 mg/dL"],["IgM","45\u2013150 mg/dL"],["Immunoglobulin free light chains, serum",""],["Kappa","3.3\u201319.4 mg/L"],["Lambda","5.7\u201326.3 mg/L"],["Kappa-to-lambda ratio","0.26\u20131.65"],["Insulin, serum (fasting)","\u02C220 \u03BCU/mL"],["Insulin-like growth factor 1 (IGF-1)",""],["(somatomedin-C), serum",""],["Ages 16\u201324","182\u2013780 ng/mL"],["Ages 25\u201339","114\u2013492 ng/mL"],["Ages 40\u201354","90\u2013360 ng/mL"],["Ages 55 and older","71\u2013290 ng/mL"],["Iodine, urine",""],["Random (\u0022spot\u0022)","\u00B5g/L; varies"],["Iron, serum","50\u2013150 \u03BCg/dL"],["Iron-binding capacity, serum (total)","250\u2013310 \u03BCg/dL"],["LBXSLDSI","80\u2013225 U/L"],["Lactate, arterial blood","\u02C21.3 mmol/L (\u02C21.3 mEq/L)"],["Lactate, serum or plasma","0.7\u20132.1 mmol/L"],["Lactate, venous blood","0.7\u20131.8 mEq/L; 6\u201316 mg/dL"],["Lactic acid, serum","6\u201319 mg/dL (0.7\u20132.1 mmol/L)"],["Lactose tolerance test, GI","Increase in plasma glucose: \u003E15 mg/dL"],["Lead, blood","\u003C5.0 \u03BCg/dL"],["LBXWBCSI","4000\u201311,000/\u03BCL"],["LBXNEPCT","50%\u201370%"],["Band forms","0%\u20135%"],["LBXLYPCT","30%\u201345%"],["LBXMOPCT","0%\u20136%"],["LBXBAPCT","0%\u20131%"],["LBXEOPCT","0%\u20133%"],["Lipase, serum","10\u2013140 U/L"],["Lipoprotein(a), serum","Desirable: \u02C230 mg/dL"],["Luteinizing hormone (LH), serum",""],["Female, follicular/luteal","1\u201312 mIU/mL (1\u201312 U/L)"],["Female, mid-cycle peak","9\u201380 mIU/mL (9\u201380 U/L)"],["Female, postmenopausal","\u003E30 mIU/mL (\u003E30 U/L)"],["Male (adult)","2\u20139 mIU/mL (2\u20139 U/L)"],["Children, Tanner stages 1, 2, 3","\u02C29.0 mIU/mL (\u02C29.0 U/L)"],["Children, Tanner stages 4, 5","1\u201315 mIU/mL (1\u201315 U/L)"],["","7"],["Lymphocyte subsets",""],["CD3","900\u20133245/\u03BCL"],["CD4","530\u20131570/\u03BCL"],["CD8","430\u20131060/\u03BCL"],["CD19","208\u2013590/\u03BCL"],["CD56","40\u2013500/\u00B5L"],["Magnesium, serum","1.6\u20132.6 mg/dL"],["Magnesium, urine","14\u2013290 mg/24 hr"],["LBXMCHSI","28\u201332 pg"],["LBXMC","33\u201336 g/dL"],["LBXMCVSI","80\u201398 fL"],["LBXMPSI","7\u20139 fL"],["Metanephrines, fractionated, plasma",""],["Metanephrine","\u02C20.5 nmol/L"],["Normetanephrine","\u02C20.9 nmol/L"],["Metanephrines, fractionated, 24-hour urine",""],["Metanephrine","\u02C2400 \u00B5g/24 hr"],["Normetanephrine","\u02C2900 \u00B5g/24 hr"],["Methylmalonic acid, serum","0.00\u20130.40 \u00B5mol/L"],["Myoglobin, serum","\u02C2100 \u03BCg/L"],["Norepinephrine, plasma",""],["Supine","70\u2013750 pg/mL"],["Standing","200\u20131700 pg/mL"],["Norepinephrine, urine","0\u2013100 \u03BCg/24 hr"],["Normetanephrine, fractionated, plasma","\u02C20.9 nmol/L"],["Normetanephrine, fractionated, 24-hour urine","\u02C2900 \u00B5g/24 hr"],["N -telopeptide, urine","Female: 11\u201348 nmol BCE/mmol creatinine;"],["","male: 7\u201368 nmol BCE/mmol creatinine"],["N -terminal-pro-B-type natriuretic peptide (NT-pro-BNP), If","eGFR \u003E60 mL/min/1.73 m 2"],["serum or plasma","18 \u201349 years of age"],["","Heart failure unlikely: \u2264300 pg/mL"],["","High probability of heart failure: \u2265450 pg/mL"],["","50\u201375 years of age"],["","Heart failure unlikely: \u2264300 pg/mL"],["","High probability of heart failure: \u2265900 pg/mL"],["","Older than 75 years of age"],["","Heart failure unlikely: \u2264300 pg/mL"],["","High probability of heart failure: \u22651800 pg/mL"],["If","eGFR \u003C60 mL/min/1.73 m 2"],["","18 years of age or older"],["","High probability of heart failure: \u22651200 pg/mL"],["LBXSOSSI","275\u2013295 mOsm/kg H 2 O"],["Osmolality, urine","38\u20131400 mOsm/kg H 2 O"],["Osmotic fragility of erythrocytes","Increased if hemolysis occurs in over 0.5% NaCl;"],["","decreased if hemolysis is incomplete in 0.3% NaCl"],["Osteocalcin, serum","Female: 7.2\u201327.9 ng/mL; male: 11.3\u201335.4 ng/mL"],["Oxalate, urine","\u02C240 mg/24 hr"],["Oxygen consumption","225\u2013275 mL/min"],["Oxygen saturation, arterial blood","\u226595%"],["Parathyroid hormone, serum",""],["C -terminal","150\u2013350 pg/mL"],["Intact","10\u201365 pg/mL"],["Intact (dialysis patients only)","Target: 130\u2013585 pg/mL"],["","8"],["Parathyroid hormone-related protein, serum","\u02C21.5 pmol/L"],["Partial thromboplastin time (activated)","25\u201335 seconds"],["pH, urine","4.5\u20138.0"],["Phenolsulfonphthalein, urine","At least 25% excreted by 15 minutes;"],["","40% by 30 minutes;"],["","60% by 120 minutes"],["Phosphatase (acid), serum",""],["Total","0.5\u20132.0 (Bodansky) units/mL"],["Prostatic fraction","0.1\u20130.4 unit/mL"],["Phosphatase (alkaline), serum","30\u2013120 U/L"],["Phospholipids, serum (total)","200\u2013300 mg/dL"],["LBXSPH","3.0\u20134.5 mg/dL"],["Phosphorus, urine","500\u20131200 mg/24 hr"],["LBXPLTSI","150,000\u2013450,000/\u03BCL"],["Platelet function analysis (PFA-100):",""],["Collagen\u2013epinephrine closure time","60\u2013143 seconds"],["Collagen\u2013ADP closure time","58\u2013123 seconds"],["Platelet survival rate ( 51 Cr)","10 days"],["LBXSKSI","3.5\u20135.0 mEq/L"],["Potassium, urine",""],["Random (\u0022spot\u0022)","mEq/L; varies"],["24-hour measurement","mEq/24 hr; varies with intake"],["Prealbumin, serum","16\u201330 mg/dL"],["Pregnanetriol, urine","0.2\u20133.5 mg/24 hr"],["Pressure (opening) [initial], CSF","70\u2013180 mm CSF (70\u2013180 mm H 2 O); 7\u201318 cm H 2 O"],["Procalcitonin, serum","\u22640.10 ng/mL"],["Progesterone, serum",""],["Female, follicular","0.02\u20130.9 ng/mL"],["Female, luteal","2\u201330 ng/mL"],["Male (adult)","0.12\u20130.3 ng/mL"],["Proinsulin, serum","3\u201320 pmol/L"],["Prolactin, serum","\u02C220 ng/mL"],["Prostate-specific antigen, serum","ng/mL; no specific normal or abnormal level"],["Protein C activity, plasma","65%\u2013150%"],["Protein C antigen, plasma","70%\u2013140%"],["Protein catabolic rate, urine","goal: 1.0\u20131.2 g/kg/24 hr"],["Protein S activity, plasma","57%\u2013131%"],["Protein S antigen, plasma",""],["Total","60%\u2013140%"],["Free","60%\u2013130%"],["Protein, urine",""],["Random (\u0022spot\u0022)","mg/dL; varies"],["24-hour measurement","\u02C2100 mg/24 hr"],["Proteins, CSF total","15\u201345 mg/dL"],["LBXSTP",""],["Total","5.5\u20139.0 g/dL"],["Albumin","3.5\u20135.5 g/dL"],["","9"],["Proteins, serum (continued)",""],["LBXSGB","2.0\u20133.5 g/dL"],["Alpha1","0.2\u20130.4 g/dL"],["Alpha2","0.5\u20130.9 g/dL"],["Beta","0.6\u20131.1 g/dL"],["Gamma","0.7\u20131.7 g/dL"],["Protein-to-creatinine ratio, urine","\u02C20.2 mg/mg"],["Prothrombin time, plasma","11\u201313 seconds"],["Pyruvic acid, blood","0.08\u20130.16 mmol/L"],["LBXRDW","9.0%\u201314.5%"],["Red cell mass","Female: 22.7\u201327.9 mL/kg; male: 24.9\u201332.5 mL/kg"],["Renin activity (angiotensin-I radioimmunoassay)",""],["Peripheral plasma",""],["Normal diet",""],["Supine","0.3\u20132.5 ng/mL/hr"],["Upright","0.2\u20133.6 ng/mL/hr"],["Low sodium diet",""],["Supine","0.9\u20134.5 ng/mL/hr"],["Upright","4.1\u20139.1 ng/mL/hr"],["Diuretics \u002B low sodium diet","6.3\u201313.7 ng/mL/hr"],["Renal vein concentration","Normal ratio (high:low): \u02C21.5"],["Reptilase time","10\u201312 seconds"],["Reticulocyte count","0.5%\u20131.5% of red cells"],["Reticulocyte count, absolute","25,000\u2013100,000/\u00B5L"],["Rheumatoid factor (nephelometry)","\u02C224 IU/mL"],["Rheumatoid factor, latex test for","\u22641:80"],["Ristocetin cofactor activity of plasma","See von Willebrand factor activity (ristocetin cofactor"],["","activity), plasma"],["Russell viper venom time, dilute","33\u201344 seconds"],["Sex hormone-binding globulin","Female, nonpregnant: 18\u2013144 nmol/L;"],["","male: 10\u201357 nmol/L"],["LBXSNASI","136\u2013145 mEq/L"],["Sodium, urine",""],["Random (\u0022spot\u0022)","mEq/L; varies"],["24-hour measurement","mEq/24 hr; varies with intake"],["Specific gravity, urine","1.002\u20131.030"],["Sperm density","10\u2013150 million/mL"],["Sweat test for sodium and chloride","\u02C260 mEq/L"],["T3 resin uptake","25%\u201335%"],["T-lymphocyte count, CD4","530\u20131570/\u03BCL"],["Testosterone, serum","Female: 18\u201354 ng/dL; male: 291\u20131100 ng/dL"],["Testosterone, bioavailable, serum","Female, age 18\u201369 yrs: 0.5\u20138.5 ng/dL"],["Testosterone, free, serum","Male: 70\u2013300 pg/mL"],["Thrombin time","17\u201323 seconds"],["","10"],["Thyroid function studies",""],["T3 resin uptake","25%\u201335%"],["Thyroglobulin, serum","\u02C220 ng/mL"],["Thyroidal iodine ( 123 I) uptake","5%\u201330% of administered dose at 24 hours"],["Thyroid-stimulating hormone (TSH), serum","0.5\u20134.0 \u03BCU/mL (0.5\u20134.0 mU/L)"],["Thyroid-stimulating immunoglobulin (TSI)","\u02C2130%"],["Thyroxine-binding globulin, serum","12\u201327 \u00B5g/mL"],["Thyroxine index, free (estimate)","5\u201312"],["Thyroxine (T 4 ), serum",""],["Total","5\u201312 \u03BCg/dL"],["Free","0.8\u20131.8 ng/dL"],["Triiodothyronine (T 3 ), serum",""],["Total","80\u2013180 ng/dL"],["Reverse","20\u201340 ng/dL"],["Free","2.3\u20134.2 pg/mL"],["Tissue transglutaminase antibody, IgA","\u02C220 AU"],["[by chemiluminescence method]",""],["Tissue transglutaminase antibody, IgG","\u02C220 AU"],["[by chemiluminescence method]",""],["Tissue transglutaminase antibody, IgA","\u02C24.0 U/mL"],["[by ELISA]",""],["Tissue transglutaminase antibody, IgG","\u02C26.0 U/mL"],["[by ELISA]",""],["Total proteins, CSF","15\u201345 mg/dL"],["Transaminase, serum glutamic oxaloacetic (SGOT)","See Aminotransferase, serum aspartate (AST)"],["Transaminase, serum glutamic pyruvic (SGPT)","See Aminotransferase, serum alanine (ALT)"],["Transferrin saturation","20%\u201350%"],["Transferrin, serum","200\u2013400 mg/dL"],["LBXSTR",""],["Optimal","\u02C2100 mg/dL"],["Normal","\u02C2150 mg/dL"],["Borderline-high","150\u2013199 mg/dL"],["High","200\u2013499 mg/dL"],["Very high","\u003E499 mg/dL"],["Troponin I, cardiac, serum","\u22640.04 ng/mL"],["Troponin T, cardiac, serum","\u22640.01 ng/mL"],["Troponin I, cardiac, high-sensitivity, plasma","Female: \u226415 ng/L; male: \u226420 ng/L"],["Troponin T, cardiac, high-sensitivity, plasma","Female: \u226410 ng/L; male: \u226415 ng/L"],["Tryptase, serum","\u02C211.5 ng/mL"],["Urea clearance, urine",""],["Standard","40\u201360 mL/min"],["Maximal","60\u2013100 mL/min"],["Urea nitrogen, blood","8\u201320 mg/dL"],["Urea nitrogen, urine","12\u201320 g/24 hr"],["LBXSUA","3.0\u20137.0 mg/dL"],["Uric acid, urine","250\u2013750 mg/24 hr"],["Uroporphyrin, urine","10\u201330 \u03BCg/24 hr"],["Vanillylmandelic acid, urine","\u02C29 mg/24 hr"],["Venous oxygen content, mixed","14\u201316 mL/dL"],["","11"],["Venous studies, mixed, blood",""],["pH","7.32\u20137.41"],["PCO 2","42\u201353 mm Hg"],["PO 2","35\u201342 mm Hg"],["Bicarbonate","24\u201328 mEq/L"],["Oxygen saturation (SvO2)","65%\u201375%"],["Viscosity, serum","1.4\u20131.8 cp"],["Vitamin A, serum:",""],["Adult","32.5\u201378.0 \u03BCg/dL"],["Pediatric, age 1\u20132 yr (retinol)","20\u201343 \u03BCg/dL"],["Vitamin B 12 , serum","200\u2013800 pg/mL"],["Vitamin D metabolites, serum",""],["1,25-Dihydroxyvitamin D","15\u201360 pg/mL"],["(1,25-dihydroxycholecalciferol)",""],["25-Hydroxyvitamin D","30\u201360 ng/mL"],["(25-hydroxycholecalciferol)",""],["Vitamin E, serum:",""],["Adult","5.5\u201317.0 mg/L"],["Pediatric, age 1\u20132 yr (alpha-tocopherol)","2.9\u201316.6 mg/L"],["Volume, blood",""],["Plasma","Female: 43 mL/kg body weight;"],["","male: 44 mL/kg body weight"],["Red cell","Female: 20\u201330 mL/kg body weight;"],["","male: 25\u201335 mL/kg body weight"],["von Willebrand factor activity (ristocetin cofactor",""],["activity), plasma","50%\u2013150%"],["von Willebrand factor antigen, plasma","50%\u2013150%"],["Zinc, serum","75\u2013140 \u03BCg/dL"],["Revised - January 2025",""],["","12"]]